{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:52:51Z","timestamp":1762077171961,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Defense Threat Reduction Agency","award":["CB10647","CB10794"],"award-info":[{"award-number":["CB10647","CB10794"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>The microbial pathogens Burkholderia pseudomallei and Bacillus anthracis are unrelated bacteria, yet both are the etiologic agents of naturally occurring diseases in animals and humans and are classified as Tier 1 potential biothreat agents. B. pseudomallei is the gram-negative bacterial agent of melioidosis, a major cause of sepsis and mortality globally in endemic tropical and subtropical regions. B. anthracis is the gram-positive spore-forming bacterium that causes anthrax. Infections acquired by inhalation of these pathogens are challenging to detect early while the prognosis is best; and they possess innate multiple antibiotic resistance or are amenable to engineered resistance. Previous studies showed that the early generation, rarely used aminocoumarin novobiocin was very effective in vitro against a range of highly disparate biothreat agents. The objective of the current research was to begin to characterize the therapeutic efficacy of novobiocin in mouse models of anthrax and melioidosis. The antibiotic was highly efficacious against infections by both pathogens, especially B. pseudomallei. Our results supported the concept that specific older generation antimicrobials can be effective countermeasures against infection by bacterial biothreat agents. Finally, novobiocin was shown to be a potential candidate for inclusion in a combined pre-exposure vaccination and post-exposure treatment strategy designed to target bacterial pathogens refractory to a single medical countermeasure.<\/jats:p>","DOI":"10.3390\/antibiotics11121685","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T02:55:51Z","timestamp":1669172151000},"page":"1685","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of Treatment with the Antibiotic Novobiocin against Infection with Bacillus anthracis or Burkholderia pseudomallei"],"prefix":"10.3390","volume":"11","author":[{"given":"Christopher P.","family":"Klimko","sequence":"first","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Welkos","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Shoe","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Mou","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Hunter","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel O.","family":"Rill","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"DeShazer","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Cote","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD 21702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dance, D.A., and Limmathurotsakul, D. (2018). Global Burden and Challenges of Melioidosis. Trop. Med. Infect Dis., 3.","DOI":"10.3390\/tropicalmed3010013"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1204699","article-title":"Melioidosis","volume":"367","author":"Wiersinga","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_3","unstructured":"Turnbull, P. (2008). Anthrax in Humans and Animals, World Health Organization. [4th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"TBS-0001-2012","DOI":"10.1128\/microbiolspec.TBS-0001-2012","article-title":"Animal Models for the Pathogenesis, Treatment, and Prevention of Infection by Bacillus anthracis","volume":"3","author":"Welkos","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"ref_6","unstructured":"(2022, November 09). 2020 Annual Report of the Federal Select Agent Program, Available online: www.selectagents.gov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/id500013t","article-title":"A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV","volume":"1","author":"Bisacchi","year":"2015","journal-title":"ACS Infect Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104050","DOI":"10.1016\/j.micpath.2020.104050","article-title":"Combinations of early generation antibiotics and antimicrobial peptides are effective against a broad spectrum of bacterial biothreat agents","volume":"142","author":"Cote","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"106002","DOI":"10.1016\/j.ijantimicag.2020.106002","article-title":"Revisiting aminocoumarins for the treatment of melioidosis","volume":"56","author":"Willcocks","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1021\/cb300269g","article-title":"A forward chemical screen identifies antibiotic adjuvants in Escherichia coli","volume":"7","author":"Taylor","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jac\/dkh471","article-title":"Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents","volume":"54","author":"Thibault","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e00612-17","DOI":"10.1128\/AAC.00612-17","article-title":"In Vitro Antibiotic Susceptibilities of Francisella tularensis Determined by Broth Microdilution following CLSI Methods","volume":"61","author":"Heine","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1128\/JCM.03251-15","article-title":"Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis, Yersinia pestis, and Burkholderia pseudomallei by Use of Laser Light Scattering Technology","volume":"54","author":"Bugrysheva","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cid\/ciy069","article-title":"Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei","volume":"67","author":"Sarovich","year":"2018","journal-title":"Clin. Infect Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e00592-20","DOI":"10.1128\/mBio.00592-20","article-title":"Burkholderia ubonensis Meropenem Resistance: Insights into Distinct Properties of Class A beta-Lactamases in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Bacteria","volume":"11","author":"Somprasong","year":"2020","journal-title":"mBio"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalation anthrax","volume":"167","author":"Friedlander","year":"1993","journal-title":"J. Infect Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1093\/cid\/ciac592","article-title":"Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review","volume":"75","author":"Parker","year":"2022","journal-title":"Clin. Infect Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.0602748103","article-title":"Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax","volume":"103","author":"Vietri","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/596063","article-title":"A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics","volume":"199","author":"Vietri","year":"2009","journal-title":"J. Infect Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0034-1398389","article-title":"Melioidosis: Evolving concepts in epidemiology, pathogenesis, and treatment","volume":"36","author":"Currie","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"Dance","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sullivan, R.P., Marshall, C.S., Anstey, N.M., Ward, L., and Currie, B.J. (2020). 2020 Review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008659"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijid.2019.01.019","article-title":"Oral eradication therapy for melioidosis: Important but not without risks","volume":"80","author":"Sullivan","year":"2019","journal-title":"Int. J. Infect Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Welkos, S.L., Klimko, C.P., Kern, S.J., Bearss, J.J., Bozue, J.A., Bernhards, R.C., Trevino, S.R., Waag, D.M., Amemiya, K., and Worsham, P.L. (2015). Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124667"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Bearss, J.J., Hunter, M., Dankmeyer, J.L., Fritts, K.A., Klimko, C.P., Weaver, C.H., Shoe, J.L., Quirk, A.V., Toothman, R.G., and Webster, W.M. (2017). Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB\/c and C57BL\/6 mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172627"},{"key":"ref_26","unstructured":"Torres, A. (2017). Animal models for melioidosis. Melioidosis and Tropical Bacterology, Springer. Current Tropical Medicine Reports."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Trevino, S.R., Klimko, C.P., Reed, M.C., Aponte-Cuadrado, M.J., Hunter, M., Shoe, J.L., Meyer, J.R., Dankmeyer, J.L., Biryukov, S.S., and Quirk, A.V. (2018). Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208277"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e141480","DOI":"10.3201\/eid2106.141480","article-title":"Consensus on the development of vaccines against naturally acquired melioidosis","volume":"21","author":"Limmathurotsakul","year":"2015","journal-title":"Emerg. Infect Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajpath.2011.03.031","article-title":"Low-dose exposure of C57BL\/6 mice to burkholderia pseudomallei mimics chronic human melioidosis","volume":"179","author":"Conejero","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/mpat.1997.0179","article-title":"BALB\/c and C57Bl\/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis","volume":"24","author":"Leakey","year":"1998","journal-title":"Microb. Pathog."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Amemiya, K., Dankmeyer, J.L., Biryukov, S.S., Trevino, S.R., Klimko, C.P., Mou, S.M., Fetterer, D.P., Garnes, P.G., Cote, C.K., and Worsham, P.L. (2019). Deletion of Two Genes in Burkholderia pseudomallei MSHR668 That Target Essential Amino Acids Protect Acutely Infected BALB\/c Mice and Promote Long Term Survival. Vaccines, 7.","DOI":"10.3390\/vaccines7040196"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/IAI.01218-10","article-title":"The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei","volume":"79","author":"Burtnick","year":"2011","journal-title":"Infect Immun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1016\/j.vaccine.2017.03.022","article-title":"Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?","volume":"35","author":"Titball","year":"2017","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fmicb.2011.00198","article-title":"Development of vaccines against burkholderia pseudomallei","volume":"2","author":"Patel","year":"2011","journal-title":"Front Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.clinthera.2010.07.020","article-title":"Progress toward development of vaccines against melioidosis: A review","volume":"32","author":"Titball","year":"2010","journal-title":"Clin. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"16937","DOI":"10.1038\/s41598-018-35382-8","article-title":"Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A\/J mouse model","volume":"8","author":"Ndumnego","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiology.166.3.3340766","article-title":"Pulmonary melioidosis: Clinical-radiologic correlation in 183 cases in northeastern Thailand","volume":"166","author":"Dhiensiri","year":"1988","journal-title":"Radiology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jcrc.2017.11.004","article-title":"Pneumonia in the tropics: Report from the Task Force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine","volume":"42","author":"Nor","year":"2017","journal-title":"J. Crit. Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1128\/AAC.04548-14","article-title":"In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods","volume":"59","author":"Heine","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"965518","DOI":"10.3389\/fmicb.2022.965518","article-title":"Evaluation of two different vaccine platforms for immunization against melioidosis and glanders","volume":"28","author":"Biryukov","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_41","first-page":"965575","article-title":"Layered and integrated medical countermeasures against Burkholderia pseudomallei infections in C57BL\/6 mice","volume":"14","author":"Klimko","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1099\/00207713-48-1-317","article-title":"Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species","volume":"48","author":"Brett","year":"1998","journal-title":"Int. J. Syst. Bacteriol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/gb-2010-11-8-r89","article-title":"Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates","volume":"11","author":"Sim","year":"2010","journal-title":"Genome Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1128\/IAI.70.9.5290-5294.2002","article-title":"A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis","volume":"70","author":"Atkins","year":"2002","journal-title":"Infect Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1099\/mic.0.000697","article-title":"A MarR family transcriptional regulator and subinhibitory antibiotics regulate type VI secretion gene clusters in Burkholderia pseudomallei","volume":"164","author":"Losada","year":"2018","journal-title":"Microbiology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nbt1183-784","article-title":"A broad host range mobilization system for in vivo genetic engineering: Tranposon mutagenesis in gram negative bacteria","volume":"1","author":"Simon","year":"1983","journal-title":"Bio. Technol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/AEM.00531-08","article-title":"Genetic tools for allelic replacement in Burkholderia species","volume":"74","author":"Barrett","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0882-4010(88)90048-4","article-title":"Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis","volume":"4","author":"Welkos","year":"1988","journal-title":"Microb. Pathog."},{"key":"ref_49","first-page":"49052","article-title":"Pathogenesis and host response to Bacillus anthracis: A mouse model","volume":"87","author":"Welkos","year":"1989","journal-title":"Salisb. Med. Bull."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.mimet.2003.10.019","article-title":"A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies","volume":"56","author":"Welkos","year":"2004","journal-title":"J. Microbiol. Methods"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/jam.12322","article-title":"D-cycloserine or similar physiochemical compounds may be uniquely suited for use in Bacillus anthracis spore decontamination strategies","volume":"115","author":"Omotade","year":"2013","journal-title":"J. Appl. Microbiol."},{"key":"ref_52","unstructured":"Council, N.R. (2011). Guide for the Care and Use of Laboratory Animals, The National Academies Press. [8th ed.]."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1128\/AAC.00267-11","article-title":"Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infections","volume":"55","author":"Welkos","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.micpath.2004.06.013","article-title":"The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores","volume":"37","author":"Cote","year":"2004","journal-title":"Microb. Pathog."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41541-017-0018-4","article-title":"Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis","volume":"2","author":"Sim","year":"2017","journal-title":"NPJ Vaccines"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1128\/IAI.72.8.4801-4809.2004","article-title":"Murine model of pulmonary anthrax: Kinetics of dissemination, histopathology, and mouse strain susceptibility","volume":"72","author":"Lyons","year":"2004","journal-title":"Infect Immun."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Klimko, C.P., Trevino, S.R., Moreau, A.M., Cuadrado, M.J.A., Meyer, J.R., Fetterer, D.P., Welkos, S.L., Worsham, P.L., Kreiselmeier, N., and Soffler, C. (2020). The Impact of Age and Sex on Mouse Models of Melioidosis. Pathogens, 9.","DOI":"10.3390\/pathogens9020113"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ijantimicag.2010.02.007","article-title":"Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci","volume":"35","author":"Huelves","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/jnci\/92.3.242","article-title":"Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins","volume":"92","author":"Marcu","year":"2000","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/12\/1685\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:24:48Z","timestamp":1760145888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/12\/1685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["antibiotics11121685"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11121685","relation":{},"ISSN":["2079-6382"],"issn-type":[{"type":"electronic","value":"2079-6382"}],"subject":[],"published":{"date-parts":[[2022,11,23]]}}}